Fig. 1From: α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathwaysEffect of ALA and TRAS, alone and in combination, on the (a) growth and (b) apoptosis of BT-474 cells. n = 3-5Back to article page